Conference Paper: Standard clarithromycin-based triple therapy is superior to levofloxacin-based triple therapy as first-line treatment for Helicobacter pylori eradication in a Chinese population

File Download
Supplementary
  • Basic View
  • Metadata View
  • XML View
TitleStandard clarithromycin-based triple therapy is superior to levofloxacin-based triple therapy as first-line treatment for Helicobacter pylori eradication in a Chinese population
AuthorsHung, IFN
Wong, BCY
Issue Date2009
Description2009 Digestive Disease Week (Chicago)
DC Field
Value
dc.contributor.authorHung, IFN
dc.contributor.authorWong, BCY
dc.date.accessioned2010-07-13T03:58:17Z
dc.date.available2010-07-13T03:58:17Z
dc.date.issued2009
dc.description2009 Digestive Disease Week (Chicago)
dc.identifier.hkuros161495
dc.identifier.urihttp://hdl.handle.net/10722/62299
dc.languageeng
dc.titleStandard clarithromycin-based triple therapy is superior to levofloxacin-based triple therapy as first-line treatment for Helicobacter pylori eradication in a Chinese population
dc.typeConference_Paper